Dark

ALNY
Alnylam Pharmaceuticals, Inc.
stock NASDAQ

At Close

Jul 9, 2025 3:59:46 PM EDT

320.84USD+1.052%(+3.34)1,039,484

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 7, 2025 8:49:30 AM EDT

332.00USD+4.567%(+14.50)0

After-hours

Jul 9, 2025 4:18:30 PM EDT

318.99USD-0.577%(-1.85)21,528

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

41.82B

CEO

John Maraganore

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Jul 30, 2025 (20d)

REGN MDCO NVS SNY TEVA SRPT IONS ARWR OPK XLV

ALNY Stats

Avg. Vol. 10 Day

1,019,888

Avg. Vol. 30 Day

933,278

Employees

749

Market Cap

41,820,773,171

Shares Out.

130,388,393

On/Off Exchange

57%/43%

6 Month Beta

1.01

1 Year Beta

0.91

2 Year Beta

0.83

3 Year Beta

0.42

52 Week Low

205.87

52 Week High

333.70

SMA50

294.12

SMA200

267.48

1 Week

-2.74%

1 Month

+5.51%

3 Month

+31.85%

6 Month

+34.78%

1 Year

+25.91%

2 Year

+60.52%

5 Year

+101.69%

Profile

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.

ALNY Stock Summary

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock price today is $320.84, and today's volume is 1,039,484. ALNY is up 1.052% today. The 30 day average volume is 933,278. ALNY market cap is 41.82B with 130,388,393 shares outstanding.